917.63
Argen X Se Adr Aktie (ARGX) Neueste Nachrichten
ClearBridge International Growth ADR ESG Portfolios Q3 2025 Commentary - Seeking Alpha
This Argenx Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Benzinga
Oppenheimer raises argenx stock price target to $1,040 on higher Vyvgart sales By Investing.com - Investing.com South Africa
Oppenheimer raises argenx stock price target to $1,040 on higher Vyvgart sales - Investing.com India
Quant Ratings Updated on 141 Stocks - InvestorPlace
Eli Lilly Upgraded, Chewy Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Argenx stock reaches all-time high at 915.55 USD By Investing.com - Investing.com Nigeria
Argenx stock reaches all-time high at 915.55 USD - Investing.com
Stocks Showing Improving Market Leadership: argenx ADR Earns 84 RS Rating - MSN
Argenx NV ADR stock hits all-time high of 855.68 USD - Investing.com Nigeria
Denali Therapeutics Announces Board and Executive Leadership Updates - GlobeNewswire Inc.
Argenx NV ADR stock hits all-time high of 855.68 USD By Investing.com - Investing.com South Africa
Janus Henderson Global Life Sciences Fund Q3 2025 Commentary - Seeking Alpha
argenx Announces VYVGART SC Prefilled Syringe for Self-Injection in Chronic Inflammatory Demyelinating Polyneuropathy Authorized for Sale by Health Canada - Barchart.com
Halozyme Beats on Q3 Earnings & Revenues, Raises 2025 View - Finviz
Piper Sandler raises argenx stock price target to $930 on strong Vyvgart sales By Investing.com - Investing.com South Africa
Piper Sandler raises argenx stock price target to $930 on strong Vyvgart sales - Investing.com
Vyvgart Fuels Strong Growth for Argenx and Supports Developing Pipeline - Morningstar
argenx SE stock price target raised to $1,146 from $800 at TD Cowen By Investing.com - Investing.com South Africa
argenx SE stock price target raised to $1,146 from $800 at TD Cowen - Investing.com India
argenx ADR earnings beat by $0.74, revenue topped estimates - Investing.com Canada
Argenx rises after Q3 earnings beat on strong sales growth By Investing.com - Investing.com South Africa
Argenx rises after Q3 earnings beat on strong sales growth - Investing.com India
argenx Reports Third Quarter 2025 Financial Results and Provides Business Update - Sahm
Baron Health Care Fund Q3 2025 Top Contributors And Detractors - Seeking Alpha
Milei's Landslide Election Victory Sends Argentina Stocks Soaring: 5 Names To Watch - Sahm
Grupo Galicia Stock Skyrockets as Milei’s Victory Fuels Argentina’s Bank Rally – What’s Next for GGAL? - ts2.tech
If You Invested $1000 In argenx Stock 5 Years Ago, You Would Have This Much Today - Sahm
ETFs Investing in argenx SE Sponsored ADR Stocks - TradingView
Argx stock hits all-time high at 821.97 USD By Investing.com - Investing.com Philippines
Argx stock hits all-time high at 821.97 USD - Investing.com India
TD Cowen Remains a Buy on Argenx Se (ARGX) - The Globe and Mail
argenx stock price target maintained at $800 by TD Cowen on strong Vyvgart uptake - Investing.com
Argenx Se (ARGX) Gets a Buy from Evercore ISI - The Globe and Mail
Assessing argenx: Insights From 12 Financial Analysts - Sahm
RBC Capital Remains a Buy on Argenx Se (ARGX) - The Globe and Mail
Argenx SE Sponsored ADR (ARGX) Stock Forecast & Price Targets: Today, Tomorrow, Next Week - Traders Union
Stocks Showing Improved Relative Strength: Zai Lab ADR - inkl
Argenx NV stock hits all-time high at 803.95 USD By Investing.com - Investing.com South Africa
Argenx NV stock hits all-time high at 803.95 USD - Investing.com
Neuromuscular Disease Therapeutics Market to Reach US$ 45.62 Billion by 2033 as Gene Therapies and RNA-based Treatments Redefine Patient Outcomes - 富途牛牛
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):